ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2330

The Turkish  Validity and Reliability of  the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL)

M Tuncay Duruoz1, Canan Sanal Top2, Ilhan Sezer3, Figen Yılmaz4, Cagri Ünal2, Hatica Sule Baklacioglu5, Firat Ulutatar6 and Pamir Atagunduz7, 1Dept of PM&R, Rheumatology Clinic, Marmara University Medical School, Istanbul, Turkey, 2PM&R, Marmara University Medical School, Istanbul, Turkey, 3Rheumatology, Physical Medicine and Rheabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 4PM&R, Sisli Hamidiye Etfal Training and Research Hospital, Istanbul, Turkey, 5Rheumatology, Marmara University Medical School, Istanbul, Turkey, 6Physical Medicine and Rehabilitation Department, Marmara University Medical School, Istanbul, Turkey, 7Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Outcome measures, quality of life, questionnaires and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Health Services Research Poster III: Patient Reported Outcomes, Patient Education and Preferences

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) is a disease-specific measure of needs-based quality of life developed in the United Kingdom (1).

Aim: To assess the validity and reliability of the L-QoL in a Turkish population.

Methods: The L-QoL was translated into Turkish using the dual-panel process. Patients with SLE were recruited from 4 different rheumatology clinics.  L-QoL administered twice with 3-4 weeks of interval to assess the test-retest reliability (intraclass correlation coefficient). Face validity was assessed via cognitive debriefing interviews with SLE patients. The convergent and divergent validities were assesed for determine the construct properties of the questionnaire. The relation of the L-QoL with subsets  of Nottingham Health Profile (NHP) (energy level, pain, emotional reactions, sleep, social isolation, physical mobility) and Health Assessment Questionnaire (HAQ) were assessed for convergent validity. The relation of the L-QoL  with non functional parameters such as age, disease duration, perceived general health and SLEDAI were assessed for divergent validity. Spearman’s correlation coeficient (rho) was used to assessed the relation between quantitative parameters. P<0.05 was accepted as significant.

Results: Fifty-five SLE patients (53 female, 2 male) with 43.55 (SD:14.33) mean of age were recruited into the study. Test–retest reliability was very good (0.87), indicating low random measurement error for the scale. The measure was well accepted and the items considered understandable and relevant which showed the face validity of Turkish version of the questionnaire. The L-QoL has good correlation with subsets of NHP and HAQ were suggesting the measure assess related but distinct constructs (convergent). Its poor and not significant correlation with non functional parameters (divergent) showed its discriminative properties (Table).

 

Convergent validity of L-QoL

Spearman’s   (rho)

Significance (p)

NHP-energy level

0.52

<0.0001

NHP-pain

0.64

<0.0001

NHP-emotional reactions

0.72

<0.0001

NHP-sleep

0.65

<0.0001

NHP-social isolation

0.60

<0.0001

NHP-physical mobility

0.53

<0.0001

HAQ

0.62

<0.0001

Divergent validity of L-QoL

Spearman’s   (rho)

Significance (p)

Age

0.19

0.1640

Disease duration

0.18

0.1930

Perceived general health

0.32

0.0460

SLEDAI

0.29

0.1000

 Conclusion: The Turkish version of L-QoL has good reliability and validity properties. It is practical and useful scale to assess the quality of life in SLE patients in Turkish population

1.  L C Doward LC, McKenna SP, Whalley D et al. The development of the L-QoL: a quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis 2009;68:196–200.


Disclosure: M. T. Duruoz, None; C. Sanal Top, None; I. Sezer, Abbvie, 8; F. Yılmaz, None; C. Ünal, None; H. S. Baklacioglu, None; F. Ulutatar, None; P. Atagunduz, None.

To cite this abstract in AMA style:

Duruoz MT, Sanal Top C, Sezer I, Yılmaz F, Ünal C, Baklacioglu HS, Ulutatar F, Atagunduz P. The Turkish  Validity and Reliability of  the Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-turkish-validity-and-reliability-of-the-systemic-lupus-erythematosus-quality-of-life-questionnaire-l-qol/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-turkish-validity-and-reliability-of-the-systemic-lupus-erythematosus-quality-of-life-questionnaire-l-qol/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology